Pune (Maharashtra) [India], October 20 (ANI): Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said that the medical firm stopped the production of the Covishield vaccine since December 2021.

Florida [US], October 8 (ANI): Florida Surgeon General, Dr Joseph A Ladapo on Saturday (local time) recommended against receiving mRNA COVID-19 vaccines, especially to males aged 18 to 39 as it increases the risk of cardiac-related death.

New Delhi [India], September 23 (ANI): The devastating COVID-19 pandemic has been a nightmare for the whole world. In fact, India ranks third in terms of the number of total cases and death count.

New Delhi [India], August 30 (ANI): With a mere 12 per cent coverage of precaution doses across the country so far, the Union Health Ministry has raised concerns over the low inoculation among eligible beneficiaries, said sources on Tuesday.

New Delhi Apr 26 PTI Seventy per cent of the people who received a booster dose of the Covid vaccine did not contract the disease during the third wave according to a new study that covered around 6000 people in IndiaThe study led by Dr Rajeev Jayadevan co-chairman of the Indian Medical Associations national task force on coronavirus said that 45 per cent of the vaccinated people who did not take a precautionary dose reported Covid in the third waveThe survey covered 5971 vaccinated people of which 24 per cent were aged below 40 and 50 per cent belonged to the 40-59 age groupWomen accounted for 45 per cent of the people surveyed while 53 per cent were healthcare workersOf the 5971 people 2383 took the booster dose and 30 per cent of them reported Covid during the third wave it said The boosted group also had a greater proportion of healthcare workers and higher N95 useThe researchers also concluded that a long gap after the second dose correlated with a higher chance of infection during the third wave Also giving a third dose before a six-month gap did not make a difference in the infection rate it saidThe study also showed that the third wave affected those aged below 40 the most -- around 45 per cent of them contracted the diseaseAround 396 per cent in the 40-59 age cohort and around 318 per cent in the 60-79 age group reported Covid during the third wave Only 212 per cent of the people aged above 80 were infected Among the 2311 people who were infected during the third wave 48 per cent were asymptomatic while 53 per cent had mild symptoms Moderate severity was reported by 415 per cent while 069 per cent had severe diseaseThe researchers said Covaxin and Covishield recipients had the same rate of infection in the third wave A total of 5157 took Covishield and 2010 39 per cent of them reported Covid during the third wave of the infection Of the 523 people who tookCovaxin 210 40 per cent reported Covid The third wave of the pandemic hit India in late December last year and subsided by MarchThe government authorised a third dose of the same vaccine forhealthcare and frontline workers and the people aged above 60 from January 10 to mitigate the severity of infections hospitalisation and death PTI GVS ANB ANB

New Delhi [India], April 12 (ANI): The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla said on Tuesday.

Pune (Maharashtra) [India], April 9 (ANI): Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose.

New Delhi [India], January 27 (ANI): Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permission in the adult population with certain conditions.

New Delhi [India], January 26 (ANI): The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.

New Delhi Jan 25 PTI COVID-19 vaccine makers Cyrus Poonawalla Krishna Ella and Suchitra Ella have been awarded Padma Bhushan the countrys third-highest civilian award on Tuesday The awards were announced on the eve of Republic Day Poonawallas Serum Institute of India manufactures COVID-19 vaccine Covishield while Bharat Biotech of Krishna Ella and Suchitra Ella produces Indias indigenous coronavirus vaccine Covaxin Subbanna Ayyappan Ajai Kumar Sonkar Sanjaya Rajaram Sanghamitra Bandyopadhyay Aditya Prasad Dash Moti Lal Madan Anil Kumar Rajvanshi and Jyantkumar Maganlal Vyas have been awarded Padma Shri under the science and technology category Under the medicine category Dr Himmatrao Bawaskar Dr Prokar Dasgupta Dr Lata Desai Dr Vijaykumar Vinayak Dongre Dr Narendra Prasad Misra Posthumous Dr Sunkara Venkata Adinarayana Rao Dr Veeraswamy Seshiah Dr Bhimsen Singhal Dr Balaji Tambe Posthumous and Dr Kamlakar Tripathi were awarded Padma Shri the fourth-highest civilian award Srimad Baba Balia Acharya Chandanaji Shakuntala Choudhary and S Damodaran were among those awarded Padma Shri in the social work category The recipient list comprises four Padma Vibhushan 17 Padma Bhushan and 107 Padma Shri awardees Thirty-four of the awardees are women PTI UZM SMN SMN